Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$435M |
| 2 |
Amazon
AMZN
|
+$334M |
| 3 |
Moderna
MRNA
|
+$53.9M |
| 4 |
Linde
LIN
|
+$44.2M |
| 5 |
DTE Energy
DTE
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.6M |
| 2 |
Comcast
CMCSA
|
+$39.7M |
| 3 |
Evergy
EVRG
|
+$38.5M |
| 4 |
Public Service Enterprise Group
PEG
|
+$38.4M |
| 5 |
Bio-Techne
TECH
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 7.14% |
| 4 | Industrials | 6.8% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Texas Instruments
TXN
$241B
| $4.8M | 0.05% |
+24,971
| New | +$4.68M |
|
377
Estee Lauder
EL
$36.9B
| $4.77M | 0.05% |
14,992
+5,203
| +53% | +$1.58M |
|
378
Atlantic Union Bankshares
AUB
$5.88B
| $4.76M | 0.05% |
131,336
+98,599
| +301% | +$3.87M |
|
379
PUT
Murphy Oil
MUR
$5.36B
| $4.72M | 0.05% |
+200,000
| New | +$4.08M |
|
|
MYOV
380
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.71M | 0.05% |
+206,778
| New | +$4.35M |
|
381
Mercado Libre
MELI
$97.5B
| $4.69M | 0.05% |
+3,012
| New | +$4.42M |
|
382
Eli Lilly
LLY
$1.12T
| $4.68M | 0.05% |
20,399
-14,736
| -42% | -$2.96M |
|
383
RingCentral
RNG
$5.6B
| $4.68M | 0.05% |
16,114
-10,677
| -40% | -$3.05M |
|
384
First Trust NASDAQ Cybersecurity ETF
CIBR
$15B
| $4.68M | 0.05% |
+100,000
| New | +$4.44M |
|
385
Royal Caribbean
RCL
$78.1B
| $4.67M | 0.05% |
54,809
+44,185
| +416% | +$3.85M |
|
386
Bruker
BRKR
$9.07B
| $4.66M | 0.05% |
61,299
+52,597
| +604% | +$3.67M |
|
387
Hillman Solutions
HLMN
$1.63B
| $4.65M | 0.05% |
+375,000
| New | +$4.18M |
|
388
Equitable Holdings
EQH
$13.3B
| $4.64M | 0.05% |
+152,547
| New | +$4.98M |
|
389
Jack in the Box
JACK
$331M
| $4.63M | 0.05% |
+41,586
| New | +$4.86M |
|
390
Uber
UBER
$161B
| $4.57M | 0.05% |
91,150
-110,909
| -55% | -$5.79M |
|
391
Lyft
LYFT
$6.61B
| $4.55M | 0.05% |
75,221
-187,752
| -71% | -$10.8M |
|
|
PFPT
392
DELISTED
Proofpoint, Inc.
PFPT
| $4.54M | 0.05% |
+26,151
| New | +$4.24M |
|
393
McCormick & Company Non-Voting
MKC
$14.9B
| $4.52M | 0.05% |
51,149
-28,845
| -36% | -$2.57M |
|
|
BLD
394
DELISTED
TopBuild
BLD
| $4.51M | 0.05% |
+22,805
| New | +$4.72M |
|
395
Invesco
IVZ
$14.1B
| $4.49M | 0.05% |
167,926
+157,706
| +1,543% | +$4.3M |
|
396
Atkore
ATKR
$3.16B
| $4.48M | 0.05% |
63,054
-29,973
| -32% | -$2.28M |
|
397
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.54B
| $4.42M | 0.05% |
+94,437
| New | +$4.48M |
|
|
VMW
398
DELISTED
VMware, Inc
VMW
| $4.41M | 0.05% |
+27,554
| New | +$4.41M |
|
399
BlackBerry
BB
$4.71B
| $4.4M | 0.05% |
+359,708
| New | +$3.77M |
|
|
XM
400
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $4.4M | 0.05% |
114,939
+90,060
| +362% | +$3.16M |
|
Similar funds
Michael Gelband's Q2 2021 Portfolio in Review
As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.
- Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
- Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
- Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
- Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
- Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
- Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
- Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.